Cipla’s Subsidiary Sells Stake In Chinese Pharma Jiangsu
Advertisement
Advertisement
Advertisement
Drug maker
“This is to inform you that Meditab Holding Limited…has entered into definitive agreement to sell its entire 48.22% equity interest in Jiangsu Cdymax Pharmaceuticals Co Ltd,
The company will be able to complete its stake sale after it obtains regulatory approvals in China.
Image Credit: Indiatimes.com
Advertisement
- Love in the time of elections: Do politics spice up or spoil dating in India?
- Samsung Galaxy S24 Plus review – the best smartphone in the S24 lineup
- Household savings dip over Rs 9 lakh cr in 3 years to Rs 14.16 lakh cr in 2022-23
- Misleading ads: SC says public figures must act with responsibility while endorsing products
- Here’s what falling inside a black hole would look like, according to a NASA supercomputer simulation
- Nothing Phone (2a) blue edition launched
- JNK India IPO allotment date
- JioCinema New Plans
- Realme Narzo 70 Launched
- Apple Let Loose event
- Elon Musk Apology
- RIL cash flows
- Charlie Munger
- Feedbank IPO allotment
- Tata IPO allotment
- Most generous retirement plans
- Broadcom lays off
- Cibil Score vs Cibil Report
- Birla and Bajaj in top Richest
- Nestle Sept 2023 report
- India Equity Market